Abstract: Described herein are synthetic promoters and/or enhancers that are specific for cancer cells and methods of engineering synthetic cancer-specific promoters.
Type:
Grant
Filed:
May 23, 2025
Date of Patent:
March 24, 2026
Assignee:
EARLI Inc.
Inventors:
Dariusz Wodziak, Shireen Rudina, Maggie C. Louie, Yue Zhang, Elizabeth Stroebele, Albert Park, David Suhy, Paul Escarpe, Cyriac Roeding, Justin Lin, Alex Harwig, Leland Harrison Hartwell
Abstract: The present disclosure encompasses embodiments of nucleic acids comprising genetic elements which are useful for the detection of diseased cells.
Type:
Grant
Filed:
August 18, 2023
Date of Patent:
October 21, 2025
Assignee:
EARLI Inc.
Inventors:
David Suhy, Paul Escarpe, Cyriac Roeding, Justin Lin, Alex Harwig, Shireen Rudina, Leland Harrison Hartwell
Abstract: The present disclosure encompasses embodiments of nucleic acids comprising genetic elements which are useful for the detection of diseased cells.
Type:
Grant
Filed:
March 31, 2021
Date of Patent:
August 13, 2024
Assignee:
EARLI Inc.
Inventors:
David Suhy, Paul Escarpe, Cyriac Roeding, Justin Lin, Alex Harwig, Shireen Rudina, Leland Harrison Hartwell
© 2026 Justia
